Position in DXCM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$100,480
+$20,836 QoQ
Shares Held
1,600
+33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $234,451 across 10 Medical Devices names. DXCM ranks #1 (42.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
This page
|
1,600 | $100,480 | |
| 2 | ABT |
Abbott Laboratories
|
521 | $53,491 | |
| 3 | SYK |
Stryker Corp
|
86 | $28,258 | |
| 4 | STE |
STERIS plc
|
91 | $20,122 | |
| 5 | PHG |
Koninklijke Philips NV
|
431 | $11,809 | |
| 6 | BSX |
Boston Scientific Corp
|
167 | $10,479 | |
| 7 | MDT |
Medtronic plc
|
56 | $4,852 | |
| 8 | PODD |
Insulet Corp
|
20 | $4,196 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,480 | 1,600 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $79,644 | 1,200 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $80,748 | 1,200 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $104,748 | 1,200 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $81,948 | 1,200 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $93,324 | 1,200 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $80,448 | 1,200 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $136,056 | 1,200 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $11,096 | 80 | Shares | Defined | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||